Recent News

• 09.23.2025 - Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
• 09.23.2025 - Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
• 09.23.2025 - Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
• 09.23.2025 - Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
• 08.20.2025 - Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
• 08.20.2025 - Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
• 08.20.2025 - Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
• 08.20.2025 - Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
• 08.04.2025 - Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
• 08.04.2025 - Mural Oncology Announces Second Quarter Financial Results and Provides Business Update

Recent Filings

• 09.12.2025 - PREM14A Preliminary proxy statements relating to merger or acquisition
• 09.02.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.02.2025 - 3 Initial statement of beneficial ownership of securities
• 08.20.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.20.2025 - 8-K Current report
• 08.20.2025 - EX-99.1 EX-99.1
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors